Remove tag commercial-content
article thumbnail

Viseven at Reuters Pharma EU

Viseven

Individual value is what drives commercial models of these companies and ensures their long-term success. Notably, the focus of pharma companies never shifted from customer-centric approach, although the rise of AI technologies was probably the hottest issue of the event.

article thumbnail

Top Commercial Benefits of Modular Approach

Viseven

Omnichannel allows to both cover the whole customer’s perspective on the internet, reaching out to him wherever it is comfortable for them across channels, and provide them with an engaging experience, being flexible with content and message delivery from channel to channel. What does modular content mean in Life Sciences?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

In its October 28 quarterly Securities and Exchange Commission (SEC) filing, the company said that Roctavian’s commercial launch is now underway. million price tag. Editorial content is independently produced and follows the highest standards of journalistic integrity. million ($1.5 million ($1.8 million at the time).

FDA 111
article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Modular content is an established practice among digital and content marketers in sectors such as FMCG and retail, who are challenged with increasing demand for more content and creating personalised content to meet the demands of their customers. Robb DeFilippis. Doing more in the digital space.

article thumbnail

CSL doses first patient with haemophilia B gene therapy Hemgenix

Pharmaceutical Technology

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. UniQure announced that it had received $100m from this first commercial sale milestone, on top of a $450m upfront payment.

FDA 98